Advertisement

Swallowing Dysfunction After Radiotherapy and Chemotherapy

  • Prameela Chelakkot
Chapter

Abstract

Treatment of head and neck tumors poses greater challenges due to the resultant functional and aesthetic outcomes and due to their proximity to critical structures like the spinal cord; brainstem; parotid glands; optic apparatus including eyes, optic nerves, and optic chiasm; lacrimal glands; cochlea; and mandible. Multidisciplinary approach has always been the standard of care, with surgery, radiotherapy, and chemotherapy remaining the main weapons in the armamentarium, with a small yet evolving role by the targeted therapies. Radical radiotherapy with concurrent platinum-based chemotherapy is often the main treatment option, in the nonsurgical management of patients with locoregionally advanced head and neck squamous cancers [1, 2].

References

  1. 1.
    Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.CrossRefGoogle Scholar
  2. 2.
    Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000;355:949–55.CrossRefGoogle Scholar
  3. 3.
    List MA, Siston A, Haraf D, Schumm P, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 1999;17:1020.CrossRefGoogle Scholar
  4. 4.
    List MA, Stracks J. Quality of life and late toxicities in head and neck cancer. Cancer Treat Res. 2003;114:331–51.CrossRefGoogle Scholar
  5. 5.
    Teguh DN, Levendag PC, Noever I, et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 2008;72:1119–27.CrossRefGoogle Scholar
  6. 6.
    Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253–62.CrossRefGoogle Scholar
  7. 7.
    Langendijk JA, Doornaert P, Rietveld DHF, Verdonck-de Leeuw IM, René Leemans C, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009;90:189–95.CrossRefGoogle Scholar
  8. 8.
    Jensen SB, Pedersen AML, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039–60.CrossRefGoogle Scholar
  9. 9.
    Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol. 2011;6:1–8.CrossRefGoogle Scholar
  10. 10.
    Bjordal K, Ahlner-Elmqvist M, Hammerlid E, et al. A prospective study of quality of life in head and neck cancer patients. Part II: longitudinal data. Laryngoscope. 2001;111:1440–52.CrossRefGoogle Scholar
  11. 11.
    Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61–70.CrossRefGoogle Scholar
  12. 12.
    Prise KM, Giuseppe Schettino MF, Held KD. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6:520–8.CrossRefGoogle Scholar
  13. 13.
    Hall S, Rudrawar S, Zunk M, et al. Protection against radiotherapy-induced toxicity. Antioxidants. 2016;5:22.CrossRefGoogle Scholar
  14. 14.
    Ward JF. DNA damage as the cause of ionizing radiation-induced gene activation. Radiat Res. 1994;138:S85–8.CrossRefGoogle Scholar
  15. 15.
    Kim JH, Jenrow KA, Brown SL. Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J. 2014;32:103–15.CrossRefGoogle Scholar
  16. 16.
    Graves PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol. 2010;20:201–7.CrossRefGoogle Scholar
  17. 17.
    Formenti SC, Demaria S, Chao K, et al. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10:718–26.CrossRefGoogle Scholar
  18. 18.
    Mavragani IV, Laskaratou DA, Frey B, et al. Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. Toxicol Res. 2016;5:12–33.CrossRefGoogle Scholar
  19. 19.
    Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol. 2010;10:210–5.CrossRefGoogle Scholar
  20. 20.
    Murry T, Carrau RL. Clinical management of swallowing disorders. 2006.Google Scholar
  21. 21.
    Smith RV, Kotz T, Beitler JJ, Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg. 2000;126:384–9.CrossRefGoogle Scholar
  22. 22.
    Morley JE. Dysphagia and aspiration. J Am Med Dir Assoc. 2015;16:631–4.CrossRefGoogle Scholar
  23. 23.
    Russi EG, Corvo R, Merlotti A, et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev. 2012;38:1033–49.CrossRefGoogle Scholar
  24. 24.
    Kronenberger MB, Meyers AD. Dysphagia following head and neck cancer surgery. Dysphagia. 1994;9:236–44.CrossRefGoogle Scholar
  25. 25.
    Kohno N, Kitahara S. Role of chemotherapy in head and neck cancer. Cancer Chemother. 2001;28:448–53.Google Scholar
  26. 26.
    King SN, Dunlap NE, Tennant PA, Pitts T. Pathophysiology of radiation-induced dysphagia in head and neck cancer. Dysphagia. 2016;31:339–51.CrossRefGoogle Scholar
  27. 27.
    Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer. 2005;5:867–75.CrossRefGoogle Scholar
  28. 28.
    Hendry JH, Zubizarreta EH. Normal tissue complications after radiation therapy. Rev Panam Salud Publica. 2006;20:151–60.CrossRefGoogle Scholar
  29. 29.
    Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:772–8.CrossRefGoogle Scholar
  30. 30.
    Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–31.CrossRefGoogle Scholar
  31. 31.
    Denham JW, Hauer-Jensen M. The radiotherapeutic injury - a complex wound. Radiother Oncol. 2002;63:129–45.CrossRefGoogle Scholar
  32. 32.
    Dörr W. Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol. 2003;79:531–7.CrossRefGoogle Scholar
  33. 33.
    Yamamori T, Yasui H, Yamazumi M, et al. Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free Radic Biol Med. 2012;53:260–70.CrossRefGoogle Scholar
  34. 34.
    Logemann JA, Pauloski BR, Rademaker AW, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck. 2008;30:148–58.CrossRefGoogle Scholar
  35. 35.
    Delanian S, Lefaix J-L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119–31.CrossRefGoogle Scholar
  36. 36.
    Pauloski BR, Rademaker AW, Logemann JA, et al. Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer. Head Neck. 2011;33:774–9.CrossRefGoogle Scholar
  37. 37.
    Remy J, Wegrowski J, Crechet F, Martin M, Daburon F. Long-term overproduction of collagen in radiation-induced fibrosis. Radiat Res. 1991;125:14–9.CrossRefGoogle Scholar
  38. 38.
    Rødningen OK, Børresen-Dale A-L, Alsner J, Hastie T, Overgaard J. Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol. 2008;86:314–20.CrossRefGoogle Scholar
  39. 39.
    Marin A, Martin M, Linan O, et al. Bystander effects and radiotherapy. Rep Pract Oncol Radiother. 2015;20:12–21.CrossRefGoogle Scholar
  40. 40.
    Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60:1425–39.CrossRefGoogle Scholar
  41. 41.
    Okunieff P, Chen Y, Maguire DJ, Huser AK. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev. 2008;27:363–74.CrossRefGoogle Scholar
  42. 42.
    Popovtzer A, Cao Y, Feng FY, Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol. 2009;93:510–5.CrossRefGoogle Scholar
  43. 43.
    Hardee JP, Puppa MJ, Fix DK, et al. The effect of radiation dose on mouse skeletal muscle remodeling. Radiol Oncol. 2014;48:247–56.CrossRefGoogle Scholar
  44. 44.
    Viet CT, Corby PM, Akinwande A, Schmidt BL. Review of preclinical studies on treatment of mucositis and associated pain. J Dent Res. 2014;93:868–75.CrossRefGoogle Scholar
  45. 45.
    Steele CM, Miller AJ. Sensory input pathways and mechanisms in swallowing: a review. Dysphagia. 2010;25:323–33.CrossRefGoogle Scholar
  46. 46.
    Prameela CG, Ravind R, et al. Dose to dysphagia aspiration-related structures and its effect on swallowing: comparison of 3D CRT and IMRT plans. Eur J Cancer. 2014;50:e38–9.CrossRefGoogle Scholar
  47. 47.
    Prameela CG, Ravind R, Renil Mon P, Sheejamol V, Dinesh M. Radiation dose to dysphagia aspiration-related structures and its effect on swallowing: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy plans. J Cancer Res Ther. 2016;12:845.CrossRefGoogle Scholar
  48. 48.
    Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68:1289–98.CrossRefGoogle Scholar
  49. 49.
    Suen AW, Chen PY, Chao K, Galerani AP, Martinez AA. Clinical correlation of radiation dose to anatomic structures with treatment related chronic dysphagia in definitive chemoradiotherapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2016;69:S419–20.CrossRefGoogle Scholar
  50. 50.
    Li B, Li D, Lau DH, et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol. 2009;4:52.CrossRefGoogle Scholar
  51. 51.
    Teguh DN, Levendag PC, Sewnaik A, et al. Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx. Radiother Oncol. 2008;89:57–63.CrossRefGoogle Scholar
  52. 52.
    Kumar R, Madanikia S, Starmer H, et al. Radiation dose to the floor of mouth muscles predicts swallowing complications following chemoradiation in oropharyngeal squamous cell carcinoma. Oral Oncol. 2014;50:65–70.CrossRefGoogle Scholar
  53. 53.
    Van Sebille YZA, Stansborough R, Wardill HR, Bateman E, Gibson RJ, Keefe DM. Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Curr Oncol Rep. 2015;17:50.CrossRefGoogle Scholar
  54. 54.
    Bensadoun RJ, Magne N, Marcy PY, Demard F. Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment. Eur Arch Otorhinolaryngol. 2001;258:481–7.CrossRefGoogle Scholar
  55. 55.
    Wang Y, Zhou X, Xu X. Oral microbiota: an overlooked etiology for chemotherapy-induced oral mucositis? J Formos Med Assoc. 2015;114:297–9.CrossRefGoogle Scholar
  56. 56.
    Sonis ST. A biological approach to mucositis. J Support Oncol. 2004;2:21–32.PubMedGoogle Scholar
  57. 57.
    Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol. 2004;15:383–8.CrossRefGoogle Scholar
  58. 58.
    Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol. 2002;20:3964–71.CrossRefGoogle Scholar
  59. 59.
    Gillespie MB, Brodsky MB, Day TA, Lee F-S, Martin-Harris B. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope. 2004;114:1362–7.CrossRefGoogle Scholar
  60. 60.
    Kann BH, Carpenter TJ, Todrov B, et al. Dysphagia and dose reduction to Dysphagia/Aspiration Related Structures (DARS) in patients receiving induction chemotherapy followed by Concurrent Chemoradiation Therapy (CTRT) for Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN). Int J Radiat Oncol Biol Phys. 2013;87:S132–3.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Prameela Chelakkot
    • 1
  1. 1.Department of Radiation OncologyAmrita Institute of Medical Sciences, Amrita Vishwa VidyapeethamKochiIndia

Personalised recommendations